Shares

9 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 15, 2024

SELL
$0.28 - $1.16 $4,968 - $20,585
-17,746 Reduced 35.76%
31,877 $10,000
Q1 2024

May 10, 2024

SELL
$1.06 - $1.67 $5,536 - $8,722
-5,223 Reduced 9.52%
49,623 $57,000
Q4 2023

Feb 14, 2024

SELL
$1.26 - $1.79 $8,944 - $12,707
-7,099 Reduced 11.46%
54,846 $92,000
Q3 2023

Nov 16, 2023

BUY
$1.61 - $2.54 $35,917 - $56,664
22,309 Added 56.28%
61,945 $112,000
Q2 2023

Jul 21, 2023

BUY
$1.14 - $1.95 $31,949 - $54,650
28,026 Added 241.4%
39,636 $73,000
Q1 2023

May 15, 2023

SELL
$1.2 - $2.19 $3,734 - $6,815
-3,112 Reduced 21.14%
11,610 $15,000
Q4 2022

Feb 10, 2023

BUY
$1.63 - $3.52 $23,996 - $51,821
14,722 New
14,722 $24,000
Q4 2021

Feb 11, 2022

SELL
$8.31 - $14.92 $226,854 - $407,301
-27,299 Closed
0 $0
Q3 2021

Nov 10, 2021

BUY
$9.15 - $13.28 $249,785 - $362,530
27,299 New
27,299 $316,000

Others Institutions Holding DNA

About Ginkgo Bioworks Holdings, Inc.


  • Ticker DNA
  • Exchange NYSE
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 1,287,779,968
  • Market Cap $9.25B
  • Description
  • Ginkgo Bioworks Holdings, Inc., together with its subsidiaries, develops platform for cell programming. Its platform is used to program cells to enable biological production of products, such as novel therapeutics, food ingredients, and chemicals derived from petroleum. The company serves various end markets, including specialty chemicals, agric...
More about DNA
Track This Portfolio

Track Creative Planning Portfolio

Follow Creative Planning and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Creative Planning, based on Form 13F filings with the SEC.

News

Stay updated on Creative Planning with notifications on news.